×
ADVERTISEMENT

JANUARY 21, 2022

Cancer Treatment May Inhibit Immune Response to COVID-19 Vaccination

By SPC News Staff

Patients with cancer who receive chemotherapy and some targeted therapies may not mount an adequate immune response to the messenger RNA (mRNA) COVID-19 vaccines, which makes booster vaccination even more important, according to a new study by researchers at Mayo Clinic Cancer Center.

The researchers wanted to know whether patients with cancer who were receiving chemotherapy or cyclin-dependent kinase 4/6 inhibitors (CDK4/6i)—abemaciclib (Verzenio, Lilly), palbociclib